Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Skicklig vård på hemmet

3 november 2026 uppdaterad av: David Levine, Brigham and Women's Hospital

Skicklig sjuksköterskevård i hemmet: En randomiserad kontrollerad prövning

We will perform a parallel-group multicenter patient-level randomized controlled evaluation of skilled nursing facility care at home. Patients typically referred to a skilled nursing facility following hospitalization will be eligible for enrollment. Instead of admission to a skilled nursing facility, participants will receive care from a technology-enabled team in their own homes or will be allocated to receive care in a traditional skilled nursing facility setting.

Studieöversikt

Status

Avslutad

Studietyp

Interventionell

Inskrivning (Faktisk)

244

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Massachusetts
      • Boston, Massachusetts, Förenta staterna, 02114
        • Massachusetts General Hospital
      • Boston, Massachusetts, Förenta staterna, 02118
        • Boston Medical Center
      • Boston, Massachusetts, Förenta staterna, 02120
        • Brigham and Women's Hospital
      • Boston, Massachusetts, Förenta staterna, 02130
        • Brigham and Women's Faulkner Hospital
      • Cambridge, Massachusetts, Förenta staterna, 02139
        • Cambridge Health Alliance

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • >=18 years old
  • Requires SNF PAC care following hospitalization, as determined by the inpatient team (requires documented rehabilitative therapy recommendation)
  • Community-dwelling before hospitalization
  • Likely to return to community-dwelling status following short-term rehabilitation as determined by RAH liaison
  • Lives within 10 miles of any study site hospital (or per specified catchment)
  • Surgical trauma and elective patients (weight bearing as tolerated and transfer with no more than one-person assist)
  • Neurology patients - Stroke (needs acute rehabilitation, but insurance will not cover, so bound for SNF. Does not meet acute rehabilitation criteria and does not need long-term placement)

Exclusion Criteria:

  • Environmental

    • Undomiciled
    • No working heat (October-April), no working air conditioning if forecast > 80°F, or no running water
    • In police custody
    • Resides in a facility that does not allow advanced on-site care
    • Domestic violence screen positive
    • Weapons that cannot be appropriately secured
    • Difficulty accessing the bathroom (unless there is space for a bedside commode where the patient sleeps or if the patient is entirely dependent on toileting)
    • Home has insufficient accessible space to sleep, eat, and perform rehabilitative therapy
    • Home lacks sufficient kitchen facilities to either cook or heat meals
    • Patient, or patient's family caregiver, unable to communicate via telephone
    • Patient, or patient's family caregiver, lacks consistent access to a telephone
  • Clinical

    • Requires more than one assist (unless the family can provide additional 24/7 assistance)
    • Requires care of new ostomy or teaching ostomy care
    • Requires frequent suctioning, tracheostomy, and ventilator needs
    • Requires total parenteral nutrition
    • Requires nasogastric tube feeds
    • Requires durable medical equipment not already in place at home and excluded below
    • Requires daily subcutaneous injection unless patient or family caregiver is teachable and able to administer daily
    • Acute delirium noted by RAH liaison requiring more than one caregiver
    • Active psychiatric diagnosis without an adequate treatment plan
    • On methadone requiring daily pickup of medication
    • Requires administration of intravenous controlled substances
    • Requires administration of specialty medications not already in place at home
    • Requires transfusion of blood products
    • Requires three times weekly or more transfers back and forth to obtain specialty medical care
    • Requires hemodialysis
    • Orthopedic trauma and elective patients
    • Traumatic brain injury
    • Wound or appliance care that requires daily nursing care
    • For spine trauma: neurologic deficits requiring more than one assist
  • Neurology patients

    • PRESS score (for ischemic stroke; use PRESS app): no return to pre-stroke diet > 50%
    • FUNC score (for primary intracerebral hemorrhage only): <75% probability of functional independence at 90 days
    • ASTRAL score (for ischemic stroke only and patients with pre-stroke independence [Modified Rankin Scale 0-2]): <75% probability of a 90-day poor functional outcome (Modified Rankin Scale result of 3-6)
  • RAH census is full

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Övrig
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Dubbel

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Inget ingripande: Usual skilled nursing facility care

Control subjects will receive care at a skilled nursing facility as per usual.

Aktiv komparator: Rehab at home

Intervention subjects will receive care in their home from a specialized care team.

Skilled nursing facility care at home delivers a range of advanced rehabilitation services in patients' homes, enabling care at home despite requiring intensive rehabilitative care. Our approach blends personalized, high-level professional care with innovative technology applications to ensure adequate rehabilitation.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in activities of daily living between admission to rehab and discharge from rehab
Tidsram: Admission to rehab until discharge from rehab, no more than 6 months

Subtract the patient's activities of daily living at discharge from rehab from the patient's activities of daily living on admission to rehab.

Admission to rehab until discharge from rehab, no more than 6 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Percent time supine per day
Tidsram: Admission to rehab until discharge from rehab, no more than 6 months

The percentage of time a patient is supine per day, as measured by their wrist-worn accelerometer.

Admission to rehab until discharge from rehab, no more than 6 months
Total direct medical expenditure
Tidsram: Admission to rehab until discharge from rehab, no more than 6 months

The percent difference in direct cost of care to deliver rehab care.

Admission to rehab until discharge from rehab, no more than 6 months
Patient experience with care
Tidsram: Admission to rehab until discharge from rehab, no more than 6 months

The Picker patient experience questionaire-15

Admission to rehab until discharge from rehab, no more than 6 months
30-day readmission or 30-day mortality
Tidsram: Discharge from rehab until 30-days later, no more than 30-days

The percentage of patients who are readmitted or deceased within 30-days of discharge from rehab.

Discharge from rehab until 30-days later, no more than 30-days

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

3 juni 2024

Primärt slutförande (Faktisk)

22 oktober 2025

Avslutad studie (Faktisk)

2 april 2026

Studieregistreringsdatum

Först inskickad

11 maj 2024

Först inskickad som uppfyllde QC-kriterierna

11 maj 2024

Första postat (Faktisk)

16 maj 2024

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

5 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

3 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • 2024P000266

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera